Skip to main content
. Author manuscript; available in PMC: 2021 Mar 18.
Published in final edited form as: Ann Surg. 2014 Dec;260(6):1103–1111. doi: 10.1097/SLA.0000000000000366

Table 3b.

Longitudinal factor levels in patients with 6h RBC:FFP ‘high ratio’ at 6h

0h 6h 12h 24h 48h 72h

PT (sec) 16.2 (14.6 – 20.6) 16.2 (15.1 – 18.3) 15.9 (15.0 – 17.0) 17.0 (15.8 – 17.7) 17.6 (15.6 – 18.8) 15.6 (15.2 – 17.3)
PTT (sec) 32.5 (27.6 – 41.8) 36.6 (32.5 – 41.7)*# 35.9 (32.8 – 40.4)*# 39.8 (36.0 – 46.4)# 47.0 (38.6 – 49.5)# 41.5 (39.4 – 45.8)
Fibrinogen (ng/mL) 139 (125 – 205) 124 (101 – 153) 183 (157 – 230) 258 (213 – 291)# 547 (530 – 566)# 668 (566 – 780)#
Factor II (%) 57.7 ± 18.3* 54.1 ± 14.9 59.4 ± 12.1 60.6 ± 12.4 61.8 ± 14.2 70.2 ± 15.4
Factor V (%) 38.0 ± 26.8 33.3 ± 16.2*# 39.7 ± 16.7# 43.2 ± 17.6 47.7 ± 25.3 61.0 ± 23.0
Factor VII (%) 73.9 ± 46.3 86.3 ± 51.8 101.1 ± 59.4 61.1 ± 36.3# 52.9 ± 19.3# 78.7 ± 32.7
Factor VIII (%) 266.6 ± 172.0* 106.4 ± 77.4# 106.2 ± 78.5# 112.5 ± 43.7# 114.1 ± 53.4# 152.6 ± 78.1#
Factor IX (%) 96.5 ± 44.2 86.5 ± 29.7* 100.7 ± 18.5* 107.1 ± 25.1 142.9 ± 36.1# 179.0 ± 53.1#
Factor X (%) 61.0 ± 23.1 54.7 ± 16.9* 62.3 ± 20.9 58.2 ± 10.4# 57.9 ± 12.9# 72.7 ± 13.0
AT III (%) 73.8 ± 23.4 67.2 ± 19.7# 74.7 ± 16.7# 71.9 ± 20.0# 61.2 ± 18.9# 66.8 ± 24.1#
Protein C (%) 79.5 ± 27.1 63.9 ± 17.8# 69.7 ± 12.9# 64.4 ± 15.1# 57.7 ± 11.9# 61.3 ± 18.6#
aPC (ng/mL) 13.7 (3.5 – 51.2) 1.4 (0.6 – 2.7)# 1.0 (0.4 – 2.3)# 0.5 (0.0 – 1.4)# 1.2 (1.1 – 1.4)# 1.2 (0.5 – 13.4)
D-dimer (mcg/mL) 7.5 (3.8 – 12.0) 6.5 (2.6 – 23.0) 7.4 (4.2 – 14.6) 7.4 (3.8 – 10.6)# 4.7 (2.8 – 6.7) 4.4 (3.2 – 6.7)
tPA (ng/mL) 25.0 (14.7 – 38.3) 12.5 (8.0 – 15.6)# 10.2 (8.4 – 14.3)# 6.8 (5.8 – 11.1)# 5.0 (4.6 – 5.3) 4.5 (3.5 – 5.4)
PAI-1 (ng/mL) 25.7 (12.4 – 38.4) 125.1 (49.5 – 132.6)# 141.6 (84.1 – 251.4)# 64.6 (43.8 – 143.4)# 27.1 (19.1 – 33.2) 19.2 (13.8 – 24.6)

PT = prothrombin time; PTT = activated partial thromboplastin time; AT III = antithrombin III; aPC = activated Protein C; tPA = tissue plasminogen activator; PAI-1 = plasminogen activator inhibitor-1. N=52.

*

p <0.05 for comparison between ‘low’ and ‘high ratio’ patients at each time point.

#

p <0.05 for comparison between admission factor level and factor level at the indicated time.